Emory University Study Maps Kratom's Complex Liver Metabolism Using Novel Molecular Network Analysis

Why it matters

Understanding how kratom alkaloids are metabolized in the liver is critical for assessing drug interaction risks, toxicity, and the true pharmacological profile of the plant. Critically, different kratom chemotypes (plant varieties) produce markedly different amounts of the potent opioid metabolite 7-hydroxymitragynine (7-OH)—with direct implications for safety and dosing.

The big picture

Kratom contains over 50 alkaloids, but researchers had previously studied them individually, missing competitive and inhibitory interactions that occur when the whole plant is consumed. This Emory University study applied a novel multilayer molecular networking approach to map metabolites from whole kratom extracts using human liver S9 fractions and high-resolution mass spectrometry. The methodology provides the most realistic picture to date of what happens biochemically when someone ingests kratom as a whole-plant product.

Key findings

• Researchers mapped the full metabolic profile of three kratom chemotypes using in vitro human liver biotransformation and LC-HRMS
• Different kratom chemotypes produced substantially different metabolic profiles, including varying levels of 7-hydroxymitragynine (7-OH) formation
• A previously unreported phase II metabolite of mitragynine (7-OH-glucuronide) was identified directly from whole kratom extracts
• The metabolism of speciofoline—a common oxindole alkaloid in commercial kratom—was characterized for the first time
• The study found that the metabolic fate of individual alkaloids changes significantly when they are present in the context of the full plant mixture rather than in isolation

What they say

According to the Emory researchers, "Application of molecular networking to mixture metabolism will enhance metabolite identification and the understanding of the therapeutic and toxicological mode(s) of action of pharmacologically active plants." The team noted that understanding competitive metabolite formation is "a critical factor in understanding the overall pharmacology of kratom, as there are numerous commercially available chemotypes."

Bottom line

The chemotype of kratom a person consumes significantly affects how much of the potent opioid metabolite 7-OH is produced in their liver—making product standardization and chemotype labeling an urgent safety and regulatory priority.